Scientists In Japan Develop Better Mouse For Leukemia Drug Research
This article was originally published in PharmAsia News
Executive Summary
Japanese scientists say they have developed a better mouse model for faster and better testing of possible drugs to treat leukemia. Current mouse models take up to eight months to develop a precursor to leukemia and often do not develop the targeted disease itself. All of the newly developed mice developed leukemia and in about six months, the researchers said in a published paper. The University of Tokyo group plans to use the new mice to study how myelodysplastic syndrome leads to leukemia, and then find a drug for it. (Click here for more - a subscription may be required
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.